NXLIW

Insider Trades

Name	Value	Action	Price	Current Price
Owens DavidDirector, Officer: Chief Medical Officer $1.3k2k shares BuyJun 10, 2024 $0.65 --
Owens DavidDirector, Officer: Chief Medical Officer $6201k shares BuyJun 10, 2024 $0.62 --
Owens DavidDirector, Officer: Chief Medical Officer $1.1k1.6k shares BuyJun 18, 2024 $0.71 --
Owens DavidDirector, Officer: Chief Medical Officer $1.8k1k shares BuyJun 28, 2024 $1.75 --
Owens DavidDirector, Officer: Chief Medical Officer $9501k shares BuyAug 13, 2024 $0.95 --
Owens DavidDirector, Officer: Chief Medical Officer $1.1k500 shares BuyOct 28, 2024 $2.19 --

Trade NXLIW

About Nexalin Technology, Inc.

Based in Houston, Texas, Nexalin Technology, Inc., founded in 2021, is a medical device firm dedicated to creating and advancing neurostimulation solutions. These products are designed to address mental health conditions within the United States and China. The company's primary offering, the Nexalin Device, is a licensed, non-invasive, and drug-free therapeutic option for managing anxiety and insomnia. This device functions by emitting a unique, patented frequency waveform that elicits a beneficial response from mid-brain structures implicated in various mental health disorders. Furthermore, Nexalin is currently developing its "Generation 2" medical device, which is undergoing clinical trials for potential treatment of opiate-related substance abuse, chronic pain, Alzheimer's disease, and dementia.

CEO: Mark White
IPO Date: Sep 16, 2022

Market Data

Open: $0.012
High: $0.0138
Low: $0.0093
Volume: 122.7K
52W High: $0.0138
52W Low: $0.0093

Valuation

Market Cap: $283k
Enterprise Value: $8.1M

Financials

Free Cash Flow: $-5.0M
Revenue: $302k
Net Income: $-8.2M
Cash: $655k
Debt: $0

Events

EarningsNov 14

actual -0.12793